In precollicular decerebrate cats and dogs the intravenous administration of naloxone reduced urinary bladder capacity. Successive cystometrograms revealed that naloxone in doses of 10–100 µg/kg i. v. reduced the volume necessary to evoke micturition by 21–67% (mean 48%) in cats and 15–81% (mean 43%) in dogs, respectively. Microinjection of fentanyl (0.4–10 nM) into the pontine micturition center (PMC) increased the bladder capacity by 4–46% (mean 18%) in cats. Naloxone injected into the same site reversed the effect of fentanyl. Microinjection of naloxone (40–120 nM) into the PMC reduced the bladder capacity by 17–57% (mean 34%) in cats. These data indicate that endogenous opioid peptides may have a role in controlling micturition in both decerebrate cat and dog, and that the enkephalinergic inhibitory mechanisms are important in modulating the micturition reflex at the level of the pontine micturition center.

Keywords:
Micturition, Bladder, Opiates, Fentanyl, Naloxone, Electrical stimulation, Chemical stimulation, Pontine micturition center
This content is only available via PDF.
© 1991 S. Karger AG, Basel
1991
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.